D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...
Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...
The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
The FDA approved a new DARZALEX FASPRO combination therapy for newly diagnosed multiple myeloma patients who are not eligible ...
Multiple Myeloma (MM) research is at the forefront of personalized medicine, driven by rapid advancements in laboratory genomics and molecular diagnostics.
Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the ...
Stocktwits on MSN
JNJ stock rises on fresh FDA approval for multiple myeloma drug
The latest approval marks the twelfth indication for Darzalex Faspro and fifth in newly diagnosed multiple myeloma. ・The ...
FDA approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple ...
MM often goes undetected until its later stages because it presents with non-specific symptoms, including fatigue, weight loss, bone pain, and recurrent infections. 2,3 However, better awareness, ...
The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...
Multiple myeloma is the second most common blood cancer in the United States, and it is more common in men, with an estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results